Navigation path

Action Group A1: Prescription and adherence action at regional level

Objectives

The overarching objective of this Action Group is to improve the quality of life and health outcomes of older people living with chronic conditions in at least 30 EU regions, through a holistic approach, including enhanced self-care, personalized care, better adequacy of treatment and increased adherence to safe and effective care plans. (p.m. the Action Plan  PDF icon 1.5 MB and the overview of the deliverables  PDF icon 888 KB )

Specific objectives include:
1. Improve patient adherence to medical plans through, for instance, IT solutions monitoring the regular intake of drugs.
2. Empower the patients and care givers to take care of their health and to be independent by, for example, improving patients' ability to understand their health status.
3. Deliver improvements in the health care systems, developing,among others things, new organisational models aimed at enhancing the competences and the connexion between health professionals.
4. Improve existing data evidence on ageing and adherence, for instance by investigating how databases can help evaluate the effect of prescriptions on citizens' health.
5. Help to better communicate with different actors in the healing and caring process.

 

Preliminary achievements

In its first year of work, the Group has drawn a more comprehensive picture of the priorities around this topic, and has been working on strengthening awareness on the importance of tackling poor adherence to medical plans and medication.

In addition to individual partners' commitments, the Group sought to build synergies based on areas of common interest and competencies. Four thematic areas have been identified: adherence to medical plans, polypharmacy, user empowerment and information, and research/methodology.

The joint effort of the partners is currently directed to deliver results in the following areas:
- innovative logistics and packaging of drugs.
- identification of best models for improving prescriptions.
- evaluation of polypharmacy tools.
- identification of risk stratification tools to be developed.
- evaluation of integrated drug management systems.

Another important strand of activity is the sharing of experiences aimed at improving the formative and training offer for healthcare professionals, with particular reference to pharmacists.

In order to facilitate replicability and deployment on bigger scale, the partners gathered Good practices  PDF icon 4.9 MB in their specific areas of expertise. 61 innovative experiences, implemented at regional or national levels, are now available, covering different subjects such as: patient empowerment and capacity to manage autonomously their own treatment; polypharmacy and monitoring of side effects of multiple medication; or improvement and monitoring of patients adherence, including the use of new technologies like mobile phone devices.

The Group also contributed to the current policy debate on the issue of adherence, for example by providing inputs and taking active role in the organisation of the international Conference on "Adherence to treatment, a public health concern at EU level" in June 2013.

Back to Top